Skip to main content
Top

Open Access 20-04-2024 | Hashimoto Thyroiditis | Original Article

CD20 + T lymphocytes in isolated Hashimoto’s thyroiditis and type 3 autoimmune polyendocrine syndrome: a pilot study

Authors: Ilaria Stramazzo, Giorgio Mangino, Silvia Capriello, Giovanna Romeo, Silvia Martina Ferrari, Poupak Fallahi, Maria Flavia Bagaglini, Marco Centanni, Camilla Virili

Published in: Journal of Endocrinological Investigation

Login to get access

Abstract

Background

CD20+ T cells represent up to 5% of circulating T lymphocytes. These cells have been shown to produce higher levels of IL-17A and IFN-γ than those of CD20 T lymphocytes. Some reports described the role of CD20+ T cells in autoimmune disorders such as multiple sclerosis and rheumatoid arthritis possibly due to their ability to produce these inflammatory cytokines. This study is aimed at describing the behavior of CD20+ T lymphocytes in the most frequent autoimmune disorder, i.e., Hashimoto’s thyroiditis (HT), presenting isolated or associated to further autoaggressive disorders in a frame of poly-autoimmunity.

Methods

The study group encompasses 65 HT patients: 23 presenting in isolated form (IT) and 42 with an associated non-endocrine autoimmune disorder [16 with chronic atrophic gastritis (CAG), 15 with nonsegmental vitiligo (VIT), and 11 with celiac disease (CD)]. Twenty healthy donors act as control group (HD). Chronic use of interfering drugs, severe or chronic disorders, and pregnancy and lactation were used as exclusion criteria. Whole blood samples (100 µl) were stained with fluorescent-labeled antibodies (anti-CD45, anti-CD3, anti-CD19, anti-CD16, anti-CD56, anti-CD4, anti-CD8, anti-CD20). Red blood cells were then lysed by adding 1 ml of hypotonic buffer, and samples were acquired on a Flow Cytometer.

Results

CD3+CD8+CD20+ T lymphocytes’ percentages, were significantly higher in the whole group of autoimmune patients compared to healthy donors (p = 0.0145). Dividing HT patients based on the type of presentation of autoimmune thyroiditis, CAG group showed the highest percentage of these cells as compared to HD and CD (p = 0.0058). IT patients showed higher percentages of CD3+ CD8+CD20+ cells than those of HD patients although not reaching statistical significance. However, dividing IT group based on thyroid function, hypothyroid patients showed higher CD8+CD20+ cell percentages than those of HD and euthyroid patients (p = 0.0111). Moreover, in IT patients, these cells were negatively correlated with FT4 levels (p = 0.0171; r = −0.4921).

Conclusions

These preliminary findings indicate that CD8+CD20+ T cells are activated in patients with autoimmune thyroiditis and may behave differently according to the presence of poly-autoimmunity and hypothyroidism.
Literature
4.
go back to reference Storie I, Wilson GA, Granger V et al (1995) Circulating CD20dim T-lymphocytes increase with age: evidence for a memory cytotoxic phenotype. Clin Lab Haematol 17(4):323–328 (PMID: 8697727)PubMed Storie I, Wilson GA, Granger V et al (1995) Circulating CD20dim T-lymphocytes increase with age: evidence for a memory cytotoxic phenotype. Clin Lab Haematol 17(4):323–328 (PMID: 8697727)PubMed
33.
go back to reference Storie I, Wilson GA, Granger V et al (1995) Circulating CD20dim T-lymphocytes increase with age: evidence for a memory cytotoxic phenotype. Clin Lab Haematol 17(4):323–328 (PMID: 8697727)PubMed Storie I, Wilson GA, Granger V et al (1995) Circulating CD20dim T-lymphocytes increase with age: evidence for a memory cytotoxic phenotype. Clin Lab Haematol 17(4):323–328 (PMID: 8697727)PubMed
Metadata
Title
CD20 + T lymphocytes in isolated Hashimoto’s thyroiditis and type 3 autoimmune polyendocrine syndrome: a pilot study
Authors
Ilaria Stramazzo
Giorgio Mangino
Silvia Capriello
Giovanna Romeo
Silvia Martina Ferrari
Poupak Fallahi
Maria Flavia Bagaglini
Marco Centanni
Camilla Virili
Publication date
20-04-2024
Publisher
Springer International Publishing
Published in
Journal of Endocrinological Investigation
Electronic ISSN: 1720-8386
DOI
https://doi.org/10.1007/s40618-024-02370-x
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.